title: Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity.
abstract: RUNX1/ETO, the fusion protein resulting from the chromosomal translocation t(8;21), is one of the most frequent translocation products in acute myeloid leukemia. Several in vitro and in vivo studies have shown that the homo-tetramerization domain of ETO, the nervy homology region 2 (NHR2), is essential for RUNX1/ETO oncogenic activity. We analyzed the energetic contribution of individual amino acids within the NHR2 to RUNX1/ETO dimer-tetramer transition and found a clustered area of 5 distinct amino acids with strong contribution to the stability of tetramers. Substitution of these amino acids abolishes tetramer formation without affecting dimer formation. Similar to RUNX1/ETO monomers, dimers failed to bind efficiently to DNA and to alter expression of RUNX1-dependent genes. RUNX1/ETO dimers do not block myeloid differentiation, are unable to enhance the self-renewal capacity of hematopoietic progenitors, and fail to induce leukemia in a murine transplantation model. Our data reveal the existence of an essential structural motif (hot spot) at the NHR2 dimer-tetramer interface, suitable for a molecular intervention in t(8;21) leukemias.
authors.affiliation: Institute for Biomedical Research, Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, Frankfurt, Germany. c.wichmann@em.uni-frankfurt.de
authors.forename: Christian
authors.initials: C
authors.lastname: Wichmann
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Becker
authors.forename: Linping
authors.initials: L
authors.lastname: Chen-Wichmann
authors.forename: Vitali
authors.initials: V
authors.lastname: Vogel
authors.forename: Anna
authors.initials: A
authors.lastname: Vojtkova
authors.forename: Julia
authors.initials: J
authors.lastname: Herglotz
authors.forename: Sandra
authors.initials: S
authors.lastname: Moore
authors.forename: Joachim
authors.initials: J
authors.lastname: Koch
authors.forename: Jörn
authors.initials: J
authors.lastname: Lausen
authors.forename: Werner
authors.initials: W
authors.lastname: Mäntele
authors.forename: Holger
authors.initials: H
authors.lastname: Gohlke
authors.forename: Manuel
authors.initials: M
authors.lastname: Grez
mesh_terms: D000595:Amino Acid Sequence; D019943:Amino Acid Substitution / Q000502:physiology; D002454:Cell Differentiation / Q000235:genetics; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D006801:Humans; D020014:K562 Cells; D007938:Leukemia / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D050505:Mutant Proteins / Q000378:metabolism / Q000502:physiology; D054730:Protein Interaction Domains and Motifs / Q000235:genetics / Q000502:physiology; D025941:Protein Interaction Mapping; D055503:Protein Multimerization / Q000502:physiology*; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D000075142:RUNX1 Translocation Partner 1 Protein; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D020298:U937 Cells
chemical_list: D050505:Mutant Proteins; D011518:Proto-Oncogene Proteins; D000075142:RUNX1 Translocation Partner 1 Protein; C082222:RUNX1T1 protein, human; D014157:Transcription Factors